Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
- PMID: 30542515
- PMCID: PMC6267593
- DOI: 10.18632/oncotarget.26330
Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
Abstract
Glioblastoma, the most frequent and lethal form of glioma, displays chromosome instability and recurrent somatic copy number alterations (SCNA). Chromothripsis and whole genome duplication (WGD) have been recently identified in cancer. In the present study, we analyzed SCNA and determine the ploidy pattern in 123 IDH-wild-type glioblastomas, using SNP array data. WGD and chromothripsis events were validated using, respectively, FISH and CTLPScanner. WGD was detected in 11.4% glioblastomas (14/123) and was associated with TP53 mutation (p = 0.0068). It was an early event occurring after the recurrent SCNA observed in diffuse high-grade gliomas. Glioblastomas with WGD were more aneuploid compared to glioblastomas without WGD (p < 0.0001). Chromothripsis occurred in 29.3% glioblastomas (36/123) and mostly affected chromosomes 7, 9 and 12, with amplification of oncogenes (EGFR, MDM2/CDK4), and homozygous deletion of tumor suppressor genes (CDKN2A). There was a significant association between chromothripsis and gene rearrangement at a given locus. WGD is an early genetic event significantly associated to TP53 mutation and leading to chromosome instability and aneuploidy in IDH-wild-type glioblastoma. Chromothripsis recurrently targets oncogenes and tumor suppressor genes that are key players in gliomagenesis and tumor progression. The occurrence of chromothripsis points to underlying gene rearrangements (including gene fusions), potential therapeutic targets in glioblastoma.
Keywords: SNP arrays; aneuploidy; chromothripsis; glioblastoma; whole genome duplication.
Conflict of interest statement
CONFLICTS OF INTEREST Authors declare no conflicts of interest.
Figures





Similar articles
-
Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor types.Neurooncol Adv. 2024 Apr 18;6(1):vdae059. doi: 10.1093/noajnl/vdae059. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38800696 Free PMC article.
-
Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma.Oncoscience. 2015 Jul 31;2(7):618-28. doi: 10.18632/oncoscience.178. eCollection 2015. Oncoscience. 2015. PMID: 26328271 Free PMC article.
-
RNA-sequencing of IDH-wild-type glioblastoma with chromothripsis identifies novel gene fusions with potential oncogenic properties.Transl Oncol. 2021 Jan;14(1):100884. doi: 10.1016/j.tranon.2020.100884. Epub 2020 Oct 15. Transl Oncol. 2021. PMID: 33074125 Free PMC article.
-
Biomarker-driven diagnosis of diffuse gliomas.Mol Aspects Med. 2015 Nov;45:87-96. doi: 10.1016/j.mam.2015.05.002. Epub 2015 May 21. Mol Aspects Med. 2015. PMID: 26004297 Review.
-
[Biology molecular of glioblastomas].Neurocirugia (Astur). 2007 Oct;18(5):373-82. Neurocirugia (Astur). 2007. PMID: 18008011 Review. Spanish.
Cited by
-
Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment.BMC Genomics. 2023 Jul 11;24(1):391. doi: 10.1186/s12864-023-09497-w. BMC Genomics. 2023. PMID: 37434117 Free PMC article.
-
Whole-Genome Doubling as a source of cancer: how, when, where, and why?Front Cell Dev Biol. 2023 Jun 5;11:1209136. doi: 10.3389/fcell.2023.1209136. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37342233 Free PMC article. Review.
-
Tumor heterogeneity assessed by sequencing and fluorescence in situ hybridization (FISH) data.Bioinformatics. 2021 Dec 11;37(24):4704-4711. doi: 10.1093/bioinformatics/btab504. Bioinformatics. 2021. PMID: 34289030 Free PMC article.
-
Identification of New Genetic Clusters in Glioblastoma Multiforme: EGFR Status and ADD3 Losses Influence Prognosis.Cells. 2020 Nov 6;9(11):2429. doi: 10.3390/cells9112429. Cells. 2020. PMID: 33172155 Free PMC article.
-
Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies.Chromosome Res. 2023 Sep 18;31(4):28. doi: 10.1007/s10577-023-09737-5. Chromosome Res. 2023. PMID: 37721639 Free PMC article. Review.
References
-
- Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-oncol. 2012;14:v1–49. https://doi.org/10.1093/neuonc/nos218 - DOI - PMC - PubMed
-
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumors of the central nervous system. IARC Lyon; 2016. 2016. - PubMed
-
- Van de Peer Y, Mizrachi E, Marchal K. The evolutionary significance of polyploidy. Nat Rev Genet. 2017;18:411–24. https://doi.org/10.1038/nrg.2017.26 - DOI - PubMed
-
- Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, Eastmond DA. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis. 2006;27:337–43. https://doi.org/10.1093/carcin/bgi218 - DOI - PubMed
-
- Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc Natl Acad Sci USA. 1996;93:7081–84. https://doi.org/10.1073/pnas.93.14.7081 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous